Diamyd Medical AB Market Cap

Diamyd Medical AB has a market cap or net worth of 158.08 million as of April 29, 2026. Its market cap has decreased by -81.81% in one year.

Market Cap

158.08M

Enterprise Value

-32.64M

Revenue

362.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

1.05

Market Cap Chart

Since May 20, 2013, Diamyd Medical AB's market cap has increased from 132.51M to 158.08M, an increase of 19.30%. That is a compound annual growth rate of 1.37%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	158.08M	-89.79%
Dec 30, 2025	1.55B	-9.52%
Dec 30, 2024	1.71B	182.47%
Dec 29, 2023	605.80M	-41.10%
Dec 30, 2022	1.03B	-9.66%
Dec 30, 2021	1.14B	-46.65%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AlzeCure Pharma AB	160.88M
Active Biotech AB	175.03M
Elicera Therapeutics AB	156.04M
Alligator Bioscience AB	151.06M
Xbrane Biopharma AB	196.16M
NextCell Pharma AB	130.33M
Initiator Pharma	214.26M
Isofol Medical AB	222.74M

Market Cap Rankings